CD47 monoclonal antibody (magrolimab biosimilar)
| Applications | ELISA, FC | 
| Reactivities | Human | 
CD47 monoclonal antibody (magrolimab biosimilar)
| Applications | ELISA, FC | 
| Reactivities | Human | 
TIM3 monoclonal antibody (cobolimab biosimilar)
| Applications | ELISA, FC | 
| Reactivities | Human | 
B7-H3 monoclonal antibody H3 (enoblituzumab biosimilar)
| Applications | ELISA, FC | 
| Reactivities | Human | 
SARS-CoV-2 monoclonal antibody (CB6 biosimilar)
| Applications | ELISA, FC | 
| Reactivities | SARS-CoV-2 | 
SARS-CoV monoclonal antibody (CR3022 biosimilar)
| Applications | ELISA, FC | 
| Reactivities | SARS-CoV-2 | 
PD-1 monoclonal antibody (pembrolizumab biosimilar)
| Applications | ELISA, FC | 
| Reactivities | Human | 
CD123 monoclonal antiody (talacotuzumab biosimilar)
| Applications | ELISA, FC | 
| Reactivities | Human | 
CD38 monoclonal antibody (daratumumab biosimilar)
| Applications | ELISA, FC | 
| Reactivities | Human | 
CD70 monoclonal antibody (vorsetuzumab biosimilar)
| Applications | ELISA, FC | 
| Reactivities | Human | 
ICOS monoclonal antibody (vopratelimab biosimilar)
| Applications | ELISA, FC | 
| Reactivities | Human | 
PDL1 monoclonal antibody (atezolizumab biosimilar)
| Applications | ELISA, FC | 
| Reactivities | Human | 
CS1 monoclonal antibody (elotuzumab biosimilar)
| Applications | ELISA, FC | 
| Reactivities | Human | 
IL6 monoclonal antibody (siltuximab biosimilar)
| Applications | ELISA, FC | 
| Reactivities | Human |